OMB
.report
Search
Disclosing illegitimate products: notifications to trading partners
Pharmaceutical Distribution Supply Chain
OMB: 0910-0806
IC ID: 218217
OMB.report
HHS/FDA
OMB 0910-0806
ICR 202407-0910-009
IC 218217
( )
Documents and Forms
Document Name
Document Type
0806 DSCSA Implementation GFI 2021 - ID of Suspect Product and Notification.pdf
Other-Agency Guidance
Information Collection (IC) Details
View Information Collection (IC)
IC Title:
Disclosing illegitimate products: notifications to trading partners
Agency IC Tracking Number:
CDER
Is this a Common Form?
No
IC Status:
Modified
Obligation to Respond:
Mandatory
CFR Citation:
Information Collection Instruments:
Document Type
Form No.
Form Name
Instrument File
URL
Available Electronically?
Can Be Submitted Electronically?
Electronic Capability
Other-Agency Guidance
0806 DSCSA Implementation GFI 2021 - ID of Suspect Product and Notification.pdf
Yes
Yes
Fillable Fileable
Federal Enterprise Architecture Business Reference Module
Line of Business:
Health
Subfunction:
Consumer Health and Safety
Privacy Act System of Records
Title:
FR Citation:
Number of Respondents:
500
Number of Respondents for Small Entity:
0
Affected Public:
Private Sector
Private Sector:
Businesses or other for-profits
Percentage of Respondents Reporting Electronically:
100 %
Requested
Program Change Due to New Statute
Program Change Due to Agency Discretion
Change Due to Adjustment in Agency Estimate
Change Due to Potential Violation of the PRA
Previously Approved
Annual Number of Responses for this IC
310,000
0
0
155,000
155,000
0
Annual IC Time Burden (Hours)
1,860,000
0
0
620,000
1,240,000
0
Annual IC Cost Burden (Dollars)
0
0
0
0
0
0
Documents for IC
Title
Document
Date Uploaded
No associated records found
Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.